Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
143.62
-1.85 (-1.27%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Guardant Health Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $171.08. The average 1-year stock price forecast is 19.12% higher than the current stock price, while the lowest is $90 (-37.33%) and the highest is $215 (+49.70%).
Price Target: $171.08 (+19.12%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 16 | 16 | 16 | 19 | 19 |
| Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Hold | 2 | 2 | 2 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 24 | 23 | 22 | 22 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $135 → $185 | Buy | Maintains | $135 → $185 | +28.81% | Jul 22, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $160 → $190 | Buy | Reiterates | $160 → $190 | +32.29% | Jul 16, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $165 → $185 | Buy | Maintains | $165 → $185 | +28.81% | Jul 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $127 → $200 | Buy | Maintains | $127 → $200 | +39.26% | Jul 15, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $135 → $205 | Buy | Reiterates | $135 → $205 | +42.74% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
1.31B
from 982.02M
Increased by 33.85%
Revenue Next Year
1.72B
from 1.31B
Increased by 30.50%
EPS This Year
-1.39
from -1.82
EPS Next Year
-0.43
from -1.39
EPS and Forward PE are based on non-GAAP adjusted numbers.